RARRES2 and neoplasm: As the chemerin analog was administered systemically via a vein, this analysis cannot distinguish direct effects of CG34 on tumor cells from indirect regulation via immune cells, cancer-associated fibroblasts, or other cells of the tumor microenvironment.